| Integrated molecular analysis of adult T cell leukemia/lymphoma K Kataoka, Y Nagata, A Kitanaka, Y Shiraishi, T Shimamura, J Yasunaga, ... Nature genetics 47 (11), 1304-1315, 2015 | 827 | 2015 |
| Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers K Kataoka, Y Shiraishi, Y Takeda, S Sakata, M Matsumoto, S Nagano, ... Nature 534 (7607), 402-406, 2016 | 674 | 2016 |
| Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation T Yoshizato, Y Nannya, Y Atsuta, Y Shiozawa, Y Iijima-Yamashita, ... Blood, The Journal of the American Society of Hematology 129 (17), 2347-2358, 2017 | 319 | 2017 |
| Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma K Kataoka, M Iwanaga, J Yasunaga, Y Nagata, A Kitanaka, T Kameda, ... Blood, The Journal of the American Society of Hematology 131 (2), 215-225, 2018 | 140 | 2018 |
| Germ line DDX41 mutations define a unique subtype of myeloid neoplasms H Makishima, R Saiki, Y Nannya, S Korotev, C Gurnari, J Takeda, ... Blood 141 (5), 534-549, 2023 | 89 | 2023 |
| Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience H Itonaga, H Tsushima, J Taguchi, T Fukushima, H Taniguchi, S Sato, ... Blood, The Journal of the American Society of Hematology 121 (1), 219-225, 2013 | 78 | 2013 |
| Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa H Itonaga, H Tsushima, T Hata, E Matsuo, D Imanishi, Y Imaizumi, ... International journal of hematology 95, 209-213, 2012 | 49 | 2012 |
| Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group M Sakai, Y Miyazaki, E Matsuo, Y Moriuchi, T Hata, T Fukushima, ... International journal of hematology 89, 319-325, 2009 | 45 | 2009 |
| Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B H Itonaga, D Imanishi, YF Wong, S Sato, K Ando, Y Sawayama, D Sasaki, ... Leukemia 28 (7), 1459-1466, 2014 | 32 | 2014 |
| Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a nationwide retrospective study H Itonaga, M Iwanaga, K Aoki, J Aoki, K Ishiyama, T Ishikawa, T Sakura, ... Leukemia research 41, 48-55, 2016 | 31 | 2016 |
| Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective … H Itonaga, S Ota, T Ikeda, H Taji, I Amano, Y Hasegawa, T Ichinohe, ... Leukemia Research 75, 50-57, 2018 | 30 | 2018 |
| Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective … H Itonaga, J Taguchi, T Fukushima, H Tsushima, S Sato, K Ando, ... Biology of Blood and Marrow Transplantation 19 (4), 607-615, 2013 | 30 | 2013 |
| Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network T Fukushima, H Itonaga, Y Moriuchi, S Yoshida, J Taguchi, Y Imaizumi, ... International journal of hematology 97, 485-490, 2013 | 30 | 2013 |
| Prognostic impact of donor source on allogeneic hematopoietic stem cell transplantation outcomes in adults with chronic myelomonocytic leukemia: a nationwide retrospective … H Itonaga, K Aoki, J Aoki, T Ishikawa, K Ishiyama, N Uchida, T Sakura, ... Biology of Blood and Marrow Transplantation 24 (4), 840-848, 2018 | 28 | 2018 |
| Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia H Matsuo, K Yoshida, K Fukumura, K Nakatani, Y Noguchi, S Takasaki, ... Blood Advances 2 (21), 2879-2889, 2018 | 27 | 2018 |
| Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. K Aoki, T Ishikawa, K Ishiyama, J Aoki, H Itonaga, T Fukuda, K Kakihana, ... British journal of haematology 168 (3), 2015 | 22 | 2015 |
| Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation K Ando, H Tsushima, E Matsuo, K Horio, S Tominaga-Sato, D Imanishi, ... Journal of Biological Chemistry 288 (13), 9457-9467, 2013 | 19 | 2013 |
| p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia N Man, G Mas, DL Karl, J Sun, F Liu, Q Yang, M Torres-Martin, H Itonaga, ... JCI insight 6 (19), 2021 | 18 | 2021 |
| Successful treatment of toxoplasmic encephalitis diagnosed early by polymerase chain reaction after allogeneic hematopoietic stem cell transplantation: two case reports and … T Miyagi, H Itonaga, F Aosai, J Taguchi, K Norose, K Mochizuki, H Fujii, ... Transplant Infectious Disease 17 (4), 593-598, 2015 | 18 | 2015 |
| Treatment with mogamulizumab or lenalidomide for relapsed adult T‐cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki transplant group … H Sakamoto, H Itonaga, Y Sawayama, T Furumoto, M Fujioka, M Chiwata, ... Hematological Oncology 38 (2), 162-170, 2020 | 17 | 2020 |